Chopra IJ, Chopra U, Smith SR, et al
Ruthie Harper, MD assesses metabolic markers alongside hormone levels to understand why weight loss has stalled
One effective way to better support individuals using GLP-1 therapies in their weight loss journeys is by leveraging digital health technology and artificial intelligence (AI)
However, when thyroid disease enters the picture, particularly autoimmune conditions like Hashimotos thyroiditis or concerns about thyroid nodules and cancer risk, the conversation around GLP-1s becomes more complex
Eli Lilly's phase 3 program for retatrutide includes multiple trials across obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease (MASLD)
This might be a few ounces of Greek yogurt, a handful of nuts, or a small portion of cottage cheese